Molecular hallmarks of excitatory and inhibitory neuronal resilience and resistance to Alzheimer’s disease

Isabel Castanho, Pourya Naderi Yeganeh, Carles A. Boix, Sarah Morgan, Hansruedi Mathys, Dmitry Prokopenko, Bartholomew White, Larisa M. Soto, Giulia Pegoraro, Saloni Shah, Athanasios Ploumakis, Nikolaos Kalavros, David A. Bennett, Christoph Lange, Doo Yeon Kim, Lars Bertram, Li-Huei Tsai, Manolis Kellis, Rudolph E. Tanzi, Yoshihide HayashizakibioRxiv 2025 · DOI

TL;DR

This study investigates the molecular and cellular mechanisms underlying cognitive resilience in Alzheimer's disease (AD), finding that resilience is an intermediate state characterized by preserved neuronal function, balanced excitatory-inhibitory activity, and specific signaling pathways in excitatory neurons. These findings highlight potential therapeutic targets for preserving cognition in AD by emulating natural protective processes.

What Problem Does This Paper Address?

Alzheimer's disease (AD) is a devastating neurodegenerative disorder characterized by cognitive decline. However, a significant portion of individuals with substantial AD pathology in their brains maintain healthy cognitive function, a phenomenon known as cognitive resilience. Understanding the biological underpinnings of this resilience is crucial for developing new therapeutic strategies that go beyond targeting amyloid plaques and tau tangles, aiming instead to bolster the brain's natural protective mechanisms. This paper addresses the gap in our understanding of the specific molecular and cellular signatures that confer resilience, and how these differ from both healthy aging and frank AD pathology.

Methods

The researchers employed a multi-omics approach, integrating bulk RNA sequencing (RNAseq) and single-nucleus RNA sequencing (snRNAseq) data from the Religious Order Study and the Rush Memory and Aging Project (ROSMAP) cohort. They categorized individuals into AD, resilient, and control groups based on neuropathological markers (amyloid-beta plaques and tau tangles) and cognitive status. Key techniques included:

  • Bulk RNAseq: Used to analyze gene expression in the dorsolateral prefrontal cortex (DLPFC) of a large cohort (n=631).
  • Single-nucleus RNAseq (snRNAseq): Applied to a smaller, multi-regional dataset (n=48) to examine cell-type-specific gene expression in DLPFC, entorhinal cortex (EC), and hippocampus (HC).
  • Pathway Activity Analysis: Employed the PanomiR package to identify dysregulated pathways.
  • Genetic Analysis: Utilized whole-genome sequencing data and polygenic risk scores (AD-PRS) to assess genetic contributions to resilience.
  • Immunofluorescence (mIF): Used to validate protein expression of key markers in brain tissue.
  • Cell-cell Communication Analysis: Employed the CellChat algorithm to infer ligand-receptor interactions between cell types.
  • Expression Weighted Cell Type Enrichment (EWCE): Used to identify cell types enriched for genes associated with rare genetic variants.

Datasets

The primary dataset used in this study was the ROSMAP (Religious Order Study and Memory and Aging Project) cohort. This dataset provided:

  • Bulk RNAseq data (n=631)
  • Multi-regional snRNAseq data (n=48)
  • Whole-genome sequencing data
  • Clinical, pathological, and neuropathological data.

The study also referenced data from previous publications, including a multi-region snRNAseq dataset from ROSMAP [18] and a whole-genome sequencing dataset [23].

Key Insights and Ideas

  • Resilience as an Intermediate State: The study suggests that cognitive resilience isn't simply the absence of AD pathology but rather an intermediate state in the AD continuum, falling between healthy aging and full-blown AD dementia.
  • Cellular Signatures of Resilience: Resilience is characterized by specific molecular and cellular adaptations, rather than a complete lack of pathology. This includes the preservation of neuronal function and the maintenance of excitatory-inhibitory balance.
  • Excitatory Neurons as Key Players: Specific subpopulations of excitatory neurons, particularly in the entorhinal cortex, show unique resilience-associated signaling pathways (neurotrophin and angiopoietin). Genes like MEF2C, ATP8B1, and RELN are identified as key markers of these resilient populations.
  • Vulnerability of Inhibitory Neurons: While excitatory neurons show resilience, certain inhibitory neuron subtypes (somatostatin-expressing SST+ interneurons) are found to be vulnerable in AD but may play a compensatory role in resilience.
  • Protein Folding Reorganization: Resilience involves a significant rewiring of protein folding and degradation pathways, with a downregulation of Hsp90 and an upregulation of Hsp40, Hsp70, and Hsp110 in excitatory neurons.

Key Results

  • Tissue-level differences: 43 genes involved in nucleic acid metabolism and signaling were differentially expressed between AD and resilient brains. Only GFAP and KLF4 showed differential expression between resilient and control groups.
  • Cellular resilience: Excitatory neurons exhibited reorganization of protein folding and degradation pathways, with Hsp90 downregulated and Hsp40, Hsp70, and Hsp110 upregulated.
  • Specific neuronal subpopulations: MEF2C-high excitatory neurons in the entorhinal cortex showed unique resilience signaling via neurotrophin (LINGO1-modulated) and angiopoietin pathways. MEF2C, ATP8B1, and RELN were identified as key markers of resilient excitatory neurons.
  • Inhibitory neuron involvement: SST+ inhibitory interneurons, despite being vulnerable in AD, showed protective roles, with RBFOX1 and KIF26B identified as markers in SST+ neurons.
  • Genetic associations: Genes associated with rare protective variants were biased towards neuronal populations, particularly SST+ and PVALB+ inhibitory neurons.
  • Cell-cell communication: Resilient subjects showed increased inferred cell-cell communication events in major cell populations in the DLPFC and EC.

Limitations and Future Work

  • Discrete Resilience Definition: The study used a discrete definition of resilience (advanced pathology with preserved cognition), which might miss individuals with moderate levels of resilience or those who would have developed dementia if they lived longer. Future studies could analyze continuous longitudinal cognitive changes.
  • Rare Variant Statistical Power: The analysis of rare genetic variants, while informative, has limitations in statistical power due to their rarity. Validation in larger cohorts is suggested.
  • Other Pathologies: The study acknowledges that other pathologies (e.g., neuroinflammation) may contribute to dementia and resilience and were not fully considered.
  • Future Directions: The authors suggest future research should focus on:
  • Mapping cellular identities to precise spatial locations to understand where resilience processes are active.
  • Investigating the role of sex differences in AD resilience pathways.
  • Exploring processes at the subcellular level, particularly within synapses.
  • Further defining the role of synaptic health in resilience.

Summary updated

Abstract

Abstract Background A significant proportion of individuals maintain healthy cognitive function despite having extensive Alzheimer’s disease (AD) pathology, known as cognitive resilience. Understanding the molecular mechanisms that protect these individuals can identify therapeutic targets for AD dementia. This study aims to define molecular and cellular signatures of cognitive resilience, protection and resistance, by integrating genetics, bulk RNA, and single-nucleus RNA sequencing data across multiple brain regions from AD, resilient, and control individuals. Methods We analyzed data from the Religious Order Study and the Rush Memory and Aging Project (ROSMAP), including bulk (n=631) and multi-regional single nucleus (n=48) RNA sequencing. Subjects were categorized into AD, resilient, and control based on β-amyloid and tau pathology, and cognitive status. We identified and prioritized protected cell populations using whole genome sequencing-derived genetic variants, transcriptomic profiling, and cellular composition distribution. Results Transcriptomic results, supported by GWAS-derived polygenic risk scores, place cognitive resilience as an intermediate state in the AD continuum. Tissue-level analysis revealed 43 genes enriched in nucleic acid metabolism and signaling that were differentially expressed between AD and resilience. Only GFAP (upregulated) and KLF4 (downregulated) showed differential expression in resilience compared to controls. Cellular resilience involved reorganization of protein folding and degradation pathways, with downregulation of Hsp90 and selective upregulation of Hsp40, Hsp70, and Hsp110 families in excitatory neurons. Excitatory neuronal subpopulations in the entorhinal cortex (ATP8B1+ and MEF2C high ) exhibited unique resilience signaling through neurotrophin (modulated by LINGO1) and angiopoietin (ANGPT2/TEK) pathways. We identified MEF2C, ATP8B1, and RELN as key markers of resilient excitatory neuronal populations, characterized by selective vulnerability in AD. Protective rare variant enrichment highlighted vulnerable populations, including somatostatin (SST) inhibitory interneurons, validated through immunofluorescence showing co-expression of rare variant associated RBFOX1 and KIF26B in SST+ neurons in the dorsolateral prefrontal cortex. The maintenance of excitatory-inhibitory balance emerges as a key characteristic of resilience. Conclusions We identified molecular and cellular hallmarks of cognitive resilience, an intermediate state in the AD continuum. Resilience mechanisms include preservation of neuronal function, maintenance of excitatory/inhibitory balance, and activation of protective signaling pathways. Specific excitatory neuronal populations appear to play a central role in mediating cognitive resilience, while a subset of vulnerable SST interneurons likely provide compensation against AD-associated dysregulation. This study offers a framework to leverage natural protective mechanisms to mitigate neurodegeneration and preserve cognition in AD.
BibTeX
@misc{castanho2025molecular,
  author = {Isabel Castanho and Pourya Naderi Yeganeh and Carles A. Boix and Sarah Morgan and Hansruedi Mathys and Dmitry Prokopenko and Bartholomew White and Larisa M. Soto and Giulia Pegoraro and Saloni Shah and Athanasios Ploumakis and Nikolaos Kalavros and David A. Bennett and Christoph Lange and Doo Yeon Kim and Lars Bertram and Li-Huei Tsai and Manolis Kellis and Rudolph E. Tanzi and Yoshihide Hayashizaki},
  title = {{Molecular hallmarks of excitatory and inhibitory neuronal resilience and resistance to Alzheimer’s disease}},
  year = {2025},
  doi = {10.1101/2025.01.13.632801},
  howpublished = {bioRxiv},
}
Figure